Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Yumeng Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2282-0814; OpenAlex author ID A5100680200. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: 2 papers

Papers 3

  1. Repositioning of Montelukast to inhibit proliferation of mutated KRAS pancreatic cancer through a novel mechanism that interfere the binding between KRAS and G… Co-author DOI 10.1016/j.ejphar.2023.176157↗
  2. Repositioning Lomitapide to block ZDHHC5-dependant palmitoylation on SSTR5 leads to anti-proliferation effect in preclinical pancreatic cancer models. Co-author DOI 10.1038/s41420-023-01359-4↗
  3. Differential expression of MAGEA6 toggles autophagy to promote pancreatic cancer progression. First author DOI 10.7554/elife.48963↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yannan Xia · 2 shared papers, 2023 · strength 0.40
  2. Yuanyuan Jiang · 2 shared papers, 2023 · strength 0.40
  3. Shengtao Yuan · 1 shared paper, 2023 · strength 0.20
  4. Li Sun · 1 shared paper, 2023 · strength 0.19
  5. Gordon Brent Mills · 1 shared paper, 2020 · strength 0.10
  6. Kenneth L. Scott · 1 shared paper, 2020 · strength 0.10
  7. Yiu Huen Tsang · 1 shared paper, 2020 · strength 0.10
  8. Sarah H. ELSEA · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.